propylnitrosourea has been researched along with procarbazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hachiya, N; Hara, T; Itoh, S; Nakajima, M; Suzuki, T | 1 |
| Casildo, A; Dad, A; Dobrovolsky, VN; Lapidus, RG; Mittelstaedt, RA; Pearce, MG; Revollo, JR; Robison, TW | 1 |
| Dobrovolsky, VN; McKinzie, PB; Revollo, JR; Robison, TW | 1 |
3 other study(ies) available for propylnitrosourea and procarbazine
| Article | Year |
|---|---|
Target organ and time-course in the mutagenicity of five carcinogens in MutaMouse: a summary report of the second collaborative study of the transgenic mouse mutation assay by JEMS/MMS.
Topics: 4-Nitroquinoline-1-oxide; 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Lac Operon; Male; Mice; Mice, Transgenic; Micronucleus Tests; Mutagens; Mutation; Nitrosamines; Nitrosourea Compounds; Organ Specificity; Procarbazine; Time Factors | 1999 |
CD59-deficient bone marrow erythroid cells from rats treated with procarbazine and propyl-nitrosourea have mutations in the Pig-a gene.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; CD59 Antigens; Male; Membrane Proteins; Mutation; Nitrosourea Compounds; Procarbazine; Rats; Rats, Inbred F344; Rats, Sprague-Dawley | 2020 |
Mutational signatures in T-lymphocytes of rats treated with N-propyl-N-nitrosourea and procarbazine.
Topics: Animals; Antineoplastic Agents; Gene Expression Regulation; Male; Mutagens; Mutation; Nitrosourea Compounds; Procarbazine; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; T-Lymphocytes; Whole Genome Sequencing | 2021 |